175 related articles for article (PubMed ID: 30009768)
1. Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation.
Zhou X; Zhao Y; Wang J; Wang X; Chen C; Yin D; Zhao F; Yin J; Guo M; Zhang L; Du L; Zhang B; Yin X
Biochem Pharmacol; 2018 Sep; 155():252-263. PubMed ID: 30009768
[TBL] [Abstract][Full Text] [Related]
2. Disturbance of Mammary UDP-Glucuronosyltransferase Represses Estrogen Metabolism and Exacerbates Experimental Breast Cancer.
Zhou X; Zheng Z; Xu C; Wang J; Min M; Zhao Y; Wang X; Gong Y; Yin J; Guo M; Guo D; Zheng J; Zhang B; Yin X
J Pharm Sci; 2017 Aug; 106(8):2152-2162. PubMed ID: 28479355
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
Singh B; Shoulson R; Chatterjee A; Ronghe A; Bhat NK; Dim DC; Bhat HK
Carcinogenesis; 2014 Aug; 35(8):1872-80. PubMed ID: 24894866
[TBL] [Abstract][Full Text] [Related]
4. The function of uterine UDP-glucuronosyltransferase 1A8 (UGT1A8) and UDP-glucuronosyltransferase 2B7 (UGT2B7) is involved in endometrial cancer based on estrogen metabolism regulation.
Zhao F; Wang X; Wang Y; Zhang J; Lai R; Zhang B; Zhou X
Hormones (Athens); 2020 Sep; 19(3):403-412. PubMed ID: 32592099
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the pure antiestrogen fulvestrant and other synthetic estrogen molecules by UDP-glucuronosyltransferase 1A enzymes expressed in breast tissue.
Chouinard S; Tessier M; Vernouillet G; Gauthier S; Labrie F; Barbier O; Bélanger A
Mol Pharmacol; 2006 Mar; 69(3):908-20. PubMed ID: 16339389
[TBL] [Abstract][Full Text] [Related]
6. Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells.
Wu J; Williams D; Walter GA; Thompson WE; Sidell N
Exp Cell Res; 2014 Nov; 328(2):351-60. PubMed ID: 25172557
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.
Singh B; Ronghe AM; Chatterjee A; Bhat NK; Bhat HK
Carcinogenesis; 2013 May; 34(5):1165-72. PubMed ID: 23492819
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
Yao Y; Brodie AM; Davidson NE; Kensler TW; Zhou Q
Breast Cancer Res Treat; 2010 Nov; 124(2):585-91. PubMed ID: 20623181
[TBL] [Abstract][Full Text] [Related]
9. Interaction between oxidative stress sensor Nrf2 and xenobiotic-activated aryl hydrocarbon receptor in the regulation of the human phase II detoxifying UDP-glucuronosyltransferase 1A10.
Kalthoff S; Ehmer U; Freiberg N; Manns MP; Strassburg CP
J Biol Chem; 2010 Feb; 285(9):5993-6002. PubMed ID: 20053997
[TBL] [Abstract][Full Text] [Related]
10. Bisphenol A induces Nrf2-dependent drug-metabolizing enzymes through nitrosylation of Keap1.
Nakamura M; Yamanaka H; Oguro A; Imaoka S
Drug Metab Pharmacokinet; 2018 Aug; 33(4):194-202. PubMed ID: 29960846
[TBL] [Abstract][Full Text] [Related]
11. [The role of NF-E2-related factor 2 in the induction of uridine 5'-diphosphate-glucuronosyltransferase 1A and its isoforms by epigallocatechin gallate in colon cancer cells].
Yang XY; Zhao WP; Li YQ; Sun ZY; Zhang Y; Guo YT; Yuan JH; Zhu Q; Wang M
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):82-7. PubMed ID: 16620709
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol and other dietary polyphenols are inhibitors of estrogen metabolism in human breast cancer cells.
Poschner S; Maier-Salamon A; Thalhammer T; Jäger W
J Steroid Biochem Mol Biol; 2019 Jun; 190():11-18. PubMed ID: 30851384
[TBL] [Abstract][Full Text] [Related]
13. Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.
Guillemette C; Bélanger A; Lépine J
Breast Cancer Res; 2004; 6(6):246-54. PubMed ID: 15535854
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer.
Singh B; Chatterjee A; Ronghe AM; Bhat NK; Bhat HK
BMC Cancer; 2013 May; 13():253. PubMed ID: 23697596
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of 17beta-estradiol-metabolizing isozymes: comparison of normal human mammary gland to normal human liver and to cultured human breast adenocarcinoma cells.
Lehmann L; Wagner J
Adv Exp Med Biol; 2008; 617():617-24. PubMed ID: 18497089
[TBL] [Abstract][Full Text] [Related]
17. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
Banerjee S; Bueso-Ramos C; Aggarwal BB
Cancer Res; 2002 Sep; 62(17):4945-54. PubMed ID: 12208745
[TBL] [Abstract][Full Text] [Related]
18. Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8.
Cheng Z; Radominska-Pandya A; Tephly TR
Arch Biochem Biophys; 1998 Aug; 356(2):301-5. PubMed ID: 9705221
[TBL] [Abstract][Full Text] [Related]
19. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells.
Harrington WR; Sengupta S; Katzenellenbogen BS
Endocrinology; 2006 Aug; 147(8):3843-50. PubMed ID: 16690804
[TBL] [Abstract][Full Text] [Related]
20. Effect of UDP-glucuronosyltransferase 1A8 polymorphism on raloxifene glucuronidation.
Kokawa Y; Kishi N; Jinno H; Tanaka-Kagawa T; Narimatsu S; Hanioka N
Eur J Pharm Sci; 2013 May; 49(2):199-205. PubMed ID: 23499758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
